Ann Kristin Kvam

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Ulf‐Henrik Mellqvist, Peter Gimsing, Øyvind Hjertner et al. · Blood · 2013 · 143 citations · Full text

Medicine, Hematology, Oncology +17

Responsiveness and minimal important score differences in quality‐of‐life questionnaires: a comparison of the EORTC QLQ‐C30 cancer‐specific questionnaire to the generic utility questionnaires EQ‐5D and 15D in patients with multiple myeloma

Ann Kristin Kvam, Peter Fayers, Finn Wislöff · European Journal Of Haematology · 2011 · 117 citations

Pharmacy, Oncology, Pharmacoeconomics +17

Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study

Tone Enden, Hilde Skuterud Wik, Ann Kristin Kvam et al. · BMJ Open · 2013 · 101 citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma

Ann Kristin Kvam, Finn Wislöff, Peter Fayers · Health and Quality of Life Outcomes · 2010 · 71 citations · Full text

Medicine, Internal Medicine, Oncology +17

What changes in health‐related quality of life matter to multiple myeloma patients? A prospective study^*

Ann Kristin Kvam, Peter Fayers, Finn Wislöff · European Journal Of Haematology · 2009 · 60 citations

Pharmacy, Biostatistics, Oncology +17